Hari Menon

1.4k total citations
73 papers, 633 citations indexed

About

Hari Menon is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Hari Menon has authored 73 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 24 papers in Pathology and Forensic Medicine and 24 papers in Oncology. Recurrent topics in Hari Menon's work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Hari Menon is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Hari Menon collaborates with scholars based in India, United States and France. Hari Menon's co-authors include Manju Sengar, Sumeet Gujral, Reena Nair, Tanuja Shet, Sridhar Epari, Rakesh Jalali, Bhausaheb Bagal, Tejpal Gupta, R Sikorski and Siddharth Laskar and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Hari Menon

65 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hari Menon India 14 233 214 189 176 119 73 633
Geoffrey Chong Australia 15 393 1.7× 179 0.8× 117 0.6× 307 1.7× 151 1.3× 59 769
Yanzhi Hsu United States 16 340 1.5× 76 0.4× 429 2.3× 187 1.1× 108 0.9× 42 891
Giulia Cervetti Italy 14 252 1.1× 265 1.2× 105 0.6× 341 1.9× 63 0.5× 37 615
Akiko Chai United States 14 193 0.8× 176 0.8× 118 0.6× 199 1.1× 129 1.1× 21 710
Tahir Latif United States 13 214 0.9× 91 0.4× 108 0.6× 93 0.5× 211 1.8× 38 588
Raffaella Marcheselli Italy 13 323 1.4× 108 0.5× 70 0.4× 304 1.7× 137 1.2× 30 594
Alessia Bari Italy 19 449 1.9× 179 0.8× 119 0.6× 550 3.1× 168 1.4× 53 911
Céline Ferlay France 15 259 1.1× 139 0.6× 460 2.4× 172 1.0× 285 2.4× 37 776
Heidi D. Finnes United States 15 693 3.0× 305 1.4× 233 1.2× 198 1.1× 135 1.1× 37 1.0k
Amanda Gordon United States 7 314 1.3× 105 0.5× 107 0.6× 116 0.7× 191 1.6× 15 801

Countries citing papers authored by Hari Menon

Since Specialization
Citations

This map shows the geographic impact of Hari Menon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hari Menon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hari Menon more than expected).

Fields of papers citing papers by Hari Menon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hari Menon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hari Menon. The network helps show where Hari Menon may publish in the future.

Co-authorship network of co-authors of Hari Menon

This figure shows the co-authorship network connecting the top 25 collaborators of Hari Menon. A scholar is included among the top collaborators of Hari Menon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hari Menon. Hari Menon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Byrne, Ashley, Daniel Le, Hari Menon, et al.. (2024). Single-cell long-read targeted sequencing reveals transcriptional variation in ovarian cancer. Nature Communications. 15(1). 6916–6916. 10 indexed citations
2.
Tembhare, Prashant, Lingaraj Nayak, Anant Gokarn, et al.. (2024). Early Immune Reconstitution Post Allogeneic Transplant and Its Impact on Outcomes According to Type of Transplant. Blood. 144(Supplement 1). 7352–7352.
3.
Cai, Xiaoyu, Minxue Jia, Tobias Heigl, et al.. (2024). IL-4-induced SOX9 confers lineage plasticity to aged adult lung stem cells. Cell Reports. 43(8). 114569–114569. 4 indexed citations
4.
5.
Menon, Hari, et al.. (2023). Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings. Indian Journal of Hematology and Blood Transfusion. 40(1). 1–11. 1 indexed citations
6.
Wang, Putianqi, Noelyn M. Kljavin, Elaine E. Storm, et al.. (2023). Adrenergic nerves regulate intestinal regeneration through IL-22 signaling from type 3 innate lymphoid cells. Cell stem cell. 30(9). 1166–1178.e8. 22 indexed citations
7.
Sengar, Manju, Hasmukh Jain, Tanuja Shet, et al.. (2022). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)‐associated lymphomas. British Journal of Haematology. 200(4). 429–439. 1 indexed citations
8.
Jain, Hasmukh, Manju Sengar, Robert Carr, et al.. (2020). Outcomes of T-lymphoblastic lymphoma treated with pediatric ALL-like protocol. Indian Journal of Cancer. 57(3). 262–262. 2 indexed citations
9.
Menon, Hari. (2018). Non-adherence to CML therapy and its clinical implications in India.. PubMed. 30(3). 142–147. 5 indexed citations
10.
Patkar, Nikhil, Asma Bibi, Sumeet Gujral, et al.. (2018). BRAFV600E mutation in hairy cell leukemia: A single-center experience. Indian Journal of Pathology and Microbiology. 61(4). 532–532. 3 indexed citations
11.
Gupta, Tejpal, Sridhar Epari, Aliasgar Moiyadi, et al.. (2017). Demographic profile, clinicopathological spectrum, and treatment outcomes of primary central nervous system tumors: Retrospective audit from an academic neuro-oncology unit. Indian Journal of Cancer. 54(4). 594–594. 4 indexed citations
12.
Glisson, Bonnie S., Benjamin Besse, Manuel Cobo, et al.. (2017). A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer. Clinical Lung Cancer. 18(6). 615–625.e8. 24 indexed citations
13.
Patkar, Nikhil, Prashant Tembhare, Hasmukh Jain, et al.. (2017). Immunogenetics of chronic lymphocytic leukemia. Indian Journal of Pathology and Microbiology. 60(1). 38–38. 5 indexed citations
14.
Shet, Tanuja, Komal Agrawal, Sridhar Epari, et al.. (2017). Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases. Indian Journal of Pathology and Microbiology. 60(4). 533–533. 2 indexed citations
15.
Jain, H. K., Manju Sengar, Hari Menon, et al.. (2016). Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma. The Indian Journal of Medical Research. 144(4). 536–543. 9 indexed citations
16.
17.
Gupta, Shilpa, et al.. (2012). Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series. Leukemia & lymphoma. 53(11). 2192–2194. 4 indexed citations
18.
Blumenschein, George R., Fairooz F. Kabbinavar, Hari Menon, et al.. (2011). A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer. Annals of Oncology. 22(9). 2057–2067. 77 indexed citations
19.
Menon, Santosh, et al.. (2009). Primary endobronchial synovial sarcoma confirmed by SYT-SSX1 fusion gene transcript by reverse transcriptase polymerase chain reaction. Indian Journal of Pathology and Microbiology. 52(4). 520–520. 10 indexed citations
20.
Jalali, Rakesh, Analabha Basu, Tejpal Gupta, et al.. (2007). Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience. British Journal of Neurosurgery. 21(6). 583–587. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geoffrey Chong Breakdown of academic impact, for papers by Yanzhi Hsu Breakdown of academic impact, for papers by Giulia Cervetti Breakdown of academic impact, for papers by Akiko Chai Breakdown of academic impact, for papers by Tahir Latif Breakdown of academic impact, for papers by Raffaella Marcheselli Breakdown of academic impact, for papers by Alessia Bari Breakdown of academic impact, for papers by Céline Ferlay Breakdown of academic impact, for papers by Heidi D. Finnes Breakdown of academic impact, for papers by Amanda Gordon
Rankless by CCL
2026